Form 4: Hippo Holdings CFO Sells 12,000 Shares Under 10b5-1 Plan
SEC Form 4
Hippo Holdings CFO, Stewart Ellis, sold 12,000 shares of common stock at a weighted average price of $25.9132 per share on December 18, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Stewart Ellis, CFO of Hippo Holdings Inc., executed a sale of 12,000 common stock shares on December 18, 2024.
- The sale was conducted under a pre-existing Rule 10b5-1 trading plan established on September 15, 2023.
- The shares were sold at a weighted average price of $25.9132, with individual trades ranging from $25.64 to $26.46.
- Following the transaction, Mr. Ellis directly owns 328,215 shares and indirectly owns 10,335 shares through a trust.
- The direct holdings include 120,525 Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan, with no indication of positive or negative sentiment. It is a neutral event.
Risks
- Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider trading activity is a common occurrence in publicly traded companies, and sales under 10b5-1 plans are generally viewed as pre-planned and not necessarily indicative of a change in the executive's outlook on the company.
Comparison to Industry Standards
- Sales by executives under 10b5-1 plans are a common practice across publicly traded companies, including those in the insurance technology sector like Lemonade and Root.
- The size of the transaction, 12,000 shares, is relatively small compared to the total outstanding shares of Hippo Holdings and is not unusual for executive sales under such plans.
- The price range of $25.64 to $26.46 is within the typical trading range for the stock at the time of the transaction.
Stakeholder Impact
- The sale of shares by a high-ranking executive could cause some short-term uncertainty among shareholders, but the pre-planned nature of the sale should mitigate any significant negative impact.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date of the 10b5-1 trading plan. |
| 12/18/2024 | Date of the stock sale transaction. |
| 12/20/2024 | Date of the SEC filing. |
Keywords
Hippo Holdings, Stewart Ellis, CFO, stock sale, 10b5-1 plan, insider trading, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.